Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review.
Joseph T MattinglyBryan L LoveBilal KhokharPublished in: PharmacoEconomics (2021)
Cost estimates for formal, informal, and non-health care services were identified in this review, but several challenges still exist in fully quantifying HCV burden. Future modeling studies including cost inputs should critically evaluate the risk of bias based on costing methods and data sources.